INTRODUCTION
Thrombotic thrombocytic purpura (TTP) and he molyticuremic syndrome (HUS) are acute fulminant disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia. Gastroenteritis is recognized as a precursor of the HUS, which is often accompanied by pain abdominal, vomiting and bloody stools. Other specific symptoms to establish the diagnosis are kidney failure and cognitive impairment [1] .
CASE REPORT
A 61yearold woman with a history of hypertension, osteoarthritis and irritable bowel syndrome presented to the emergency department (ED) after 5 d of bloody diarrhea without mucus, after eating highfat food. Her vital signs upon arrival in ED were within normal limits. Physical examination revealed diffuse abdominal tenderness on deep palpation without signs of peritonitis, spasms in the upper extremities, and muscle weakness. Finally, the patient showed slow improvement in her renal function, recovering diuresis after 3 wk. She was discharged with a platelet count of 213 × 10 3 /µL.
DISCUSSION
TTP and HUS have been considered rare diseases with high mortality. They continue to be rare in adults, although we have seen them more frequently than in the past. The prevalence of TTP is around 30%40%, whereas HUS rate is approximately 4%10%; their mortality ranges around 90% and 15%, respectively [2] . The most important reason that our patient had a positive outcome was that we never excluded HUS as a possible diagnosis. The unusual features that led us to the diagnosis were the bloody diarrhea, abdominal and diffuse pain evolving over 5 d after eating highfat food, and the abnormal blood test results, specifically the presence of hemolytic anemia and acute kidney failure [3] . Karpac et al [4] reported that the most common symptom associated with typical HUS is diarrhea; however, the majority of gastrointestinal diseases can cause this. In addition, the bloody diarrhea is often caused by Campylobacter, E. coli O157:H7, and other Shiga toxinproducing E. coli, Salmonella, Shigella, and Yersinia; however, E. coli O157:H7 is the most important pathogen, which usually causes abdominal tenderness, more than 5 watery stools in the last 24 h, and especially bloody diarrhea that frequently persists during first 8 h [5] . Incidentally, Kuehne et al [6] demonstrated that the true STEC gastroenteritis incidence in a computed estimate was 32.3fold higher than the incidence based on notified HUS cases. In addition, Pedersen et al [7] showed that the incidence rate per 100000 persons of STEC infections was highest in children < 5 years of age (32.17) and in adults ≥ 65 years of age (11.64) compared to 1564 years old population (7.89).
Regarding to the first symptoms of our patient, the appearance of ecchymoses and petechiae, besides the sudden decrease in platelets and the increase in serum creatinine confirmed our diagnosis of microangiopathy.
As indicated in the guidelines for management of microangiopathies, our firstline therapy was plasma exchange [2] combined with hemodialysis and aggressive antibiotic therapy because ESBLproducing E. coli was detected in blood cultures. However, at that time we could not differentiate between HUS and TTP. Later, the normal levels of ADAMTS 13 protease led us to the definitive diagnosis of HUS [8] .
Differentiation of HUS and TTP remains complex.
Acute renal failure is usually more severe in HUS [9] , while TTP more frequently results in damage to the central nervous system. Moake [5, 8] reported that systemic aggregation of platelets, especially in the central nervous system, usually indicates TTP because platelet aggregation in HUS is predominantly confined to the renal circulation [8] . In relation to ADMTS 13, a protein responsible for cleaving Von Willebrand factor, our patient had normal levels and this was another characteristic that assisted our diagnosis.
The key features of HUS treatment are firstly, fluid therapy with isotonic solutions to avoid the occurrence of oliguria, anuria, and the requirement for dialysis [10] . In our patient, diuresis was less than 0.5 mL/kg/h for more than 12 h, meaning that hemodialysis was necessary [11] . Secondly, the guidelines recommend blood transfusion when hemoglobin drops to 6 mg/dL, therefore, our patient required three transfusions of packed cells. Thirdly, patient needed antihypertensive therapy because patients with HUS develop arterial hypertension caused by an overexpansion of the intravascular volume and/or ischemiainduced activation of the renin-angiotensin system [12] . Finally, management with lowmolecularweight heparin was necessary to prevent a thrombotic event.
In summary, our patient presented typical clinical features of HUS. This is an uncommon disease in adults, which has a relatively good prognosis with low mortality. The gastroenterologist may encounter the HUS as it presents with primarily intestinal symptoms or may assist in the management of the abdominal complications. Anticipation of the broad clinical scope of the HUS is essential for the optimal management of this serious entity.
After contaminated food is ingested, the Shiga toxin (Figure 1) is released into the blood circulation, which leads to damage of the intestinal mucosa and the renal endothelium. Damaged renal endothelial cells promote a prothrombin state with an increase in platelet adhesion and formation of microthrombi [13] . Clinicians should consider E. coli O157:H7 when evaluating patients with diarrhea, especially those with a history of bloody diarrhea, and should be aware that patients with E. coli O157:H7 infection can get a wrong diagnosis with a noninfectious disease. Afterwards, that is the reason why it is necessary to perform culture stools for E coli 0157:H7 since may lead to early recognition of outbreaks and to implement public health control measures. Definitely, surveillance on the organism is needed to define more clearly the clinical illness, populations at risk of infection and risks and benefits of treatment methods.
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February 14, 2018|Volume 24|Issue 6| WJG|www.wjgnet.com Figure 1 Tridimensional structure of Shiga toxin. Shiga toxins are a family of related toxins with two major groups, Stx1 and Stx2, expressed by genes considered to be part of the genome of lambdoidprophages. The most common sources for Shiga toxin are the bacteria S. dysenteriae and the shigatoxigenic serotypes of Escherichia coli, which includes serotypes O157:H7, O104:H4, and other enterohemorrhagic E. coli.
